Κατεύθυνση Διεθνής Ιατρική - Διαχείριση Κρίσεων Υγείας
Library of the School of Health Sciences

2020-03-22

2020

Alexakis Leonidas

Μιχαήλ Κοντός, Αναπληρωτής Καθηγητής, Τμήμα Ιατρικής, ΕΚΠΑ, Επιβλέπων
Σωτήριος Γεωργόπουλος, Καθηγητής, Τμήμα Ιατρικής, ΕΚΠΑ
Ιωάννης Καραβοκυρός, Αναπληρωτής Καθηγητής, Τμήμα Ιατρικής, ΕΚΠΑ

Cascade of care for Hepatitis C in people who Inject drugs in the world and in Greece (2017-2018) - Case study of an HIV Cohort

English

Cascade of care for Hepatitis C in people who Inject drugs in the world and in Greece (2017-2018) - Case study of an HIV Cohort

Attention on Hepatitis C has grown over the past few years. Firstly, it is the high morbidity and mortality associated to diseases of the liver due to Hepatitis C. Secondly, many infected patients remain undiagnosed and not offered treatment. Thirdly, Hep C is now easily curable as direct-acting antivirals (DAAs) have become available. Finally, the World Health Organisation (WHO) has undertaken a vast campaign in order to eliminate HCV by the year 2030.

However, barriers exist in the cascade of care of patients suffering from HCV. These barriers are associated to the patients themselves, the providers of health services, but also are of macro-structural nature. Providing cure is hindered at various levels, as patients belong often to hard-to-reach populations. That is, because Hep C patients are frequently injecting drugs, homeless, prisoners, unemployed, have psychiatric diagnosis, uninsured, alcoholic or belong to other vulnerable groups, such as migrants. Moreover, HCV patients are frequently HIV–positive, as both viruses have a common mode of transmission.

Health Sciences

Hepatitis C, Cascade of care, Access to treatment and barriers, Direct-acting antivirals (DAAs), People who inject drugs (PWID), HCV/HIV co-infection

No

0

Yes

57

49

File access is restricted only to the intranet of UoA.

https://pergamos.lib.uoa.gr/uoa/dl/object/2899558